Clover Health Investments (CLOV) Equity Average (2020 - 2026)

Clover Health Investments (CLOV) has 7 years of Equity Average data on file, last reported at $324.1 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 4.3% year-over-year to $324.1 million; the trailing twelve-month figure through Mar 2026 stood at $324.1 million (down 4.3% YoY), and the FY2025 full-year result was $324.9 million, up 3.56% from the prior year.
• Equity Average for Q1 2026 stood at $324.1 million, roughly flat from $324.8 million in the prior quarter.
• Across five years, Equity Average topped out at $515.2 million in Q1 2022 and bottomed at $289.4 million in Q1 2024.
• The 5-year median for Equity Average is $338.6 million (2025), against an average of $352.9 million.
• The widest annual swing landed in 2022, when Equity Average surged 4347.65%; it then slumped 34.01% in 2023.
• A 5-year view of Equity Average shows it stood at $374.5 million in 2022, then declined by 18.8% to $304.1 million in 2023, then gained by 12.34% to $341.7 million in 2024, then decreased by 4.93% to $324.8 million in 2025, then retreated by 0.23% to $324.1 million in 2026.
• The last three Equity Average figures came in at $324.1 million (Q1 2026), $324.8 million (Q4 2025), and $342.6 million (Q3 2025), per Business Quant data.

Peer Comparison